The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

26 Feb 2018 16:25

RNS Number : 9693F
Maven Income & Growth VCT 4 PLC
26 February 2018
 

Maven Income and Growth VCT 4 PLC

 

Net Asset Value

 

The Directors of Maven Income and Growth VCT 4 PLC (the Company) confirm that the unaudited net asset value of the Company as at 31 December 2017 was 85.97p per Ordinary Share.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 31 December 2017 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

26 February 2018

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVUNUNRWSAUUAR
Date   Source Headline
14th Aug 200811:31 amRNSInterim Results
7th Aug 200812:49 pmRNSDirectorate Change
19th May 20083:30 pmRNSInterim Management Statement
15th May 20083:50 pmRNSAGM Statement
7th May 20089:30 amRNSAnnual Information Update
6th May 200811:36 amRNSAnnual Report and Accounts
12th Mar 200811:00 amRNSDividend Declaration
28th Feb 20084:36 pmRNSFinal Results
12th Sep 20072:56 pmRNSInterim Results
1st Aug 20071:19 pmRNSTotal Voting Rights
1st Aug 20071:15 pmRNSIssue of Equity
13th Jul 20073:06 pmRNSIssue of Equity
28th Jun 20074:20 pmRNSExtension of Offer period
12th Jun 20074:40 pmRNSAnnual Information Update
11th Jun 20074:47 pmRNSResult of AGM
10th Apr 20074:32 pmRNSIssue of Equity
2nd Apr 20074:19 pmRNSIssue of Equity
1st Mar 20074:38 pmRNSIssue of Equity
23rd Feb 20073:04 pmRNSFinal Results
20th Dec 20064:54 pmRNSTotal Voting Rights
5th Dec 200611:14 amRNSDividend Declaration
8th Nov 20062:20 pmRNSNet Asset Value(s)
6th Oct 20063:52 pmRNSPublication of Prospectus
5th Oct 20064:25 pmRNSEGM Statement
5th Oct 20062:54 pmRNSDividend Declaration
5th Oct 200612:54 pmRNSDividend Declaration
6th Sep 20064:23 pmRNSNotice of EGM
23rd Aug 20064:28 pmRNSInterim Results
22nd Jun 20069:36 amRNSAnnual Information Update
21st Jun 20069:13 amRNSResult of AGM
8th Feb 20064:46 pmRNSFinal Results
1st Dec 20054:30 pmRNSInvestment Activity
1st Nov 20053:59 pmRNSDirectorate Change
15th Sep 200511:52 amRNSFurther re Issue of Equity
12th Sep 20058:41 amRNSIssue of Equity
31st Aug 20054:25 pmRNSInterim Results
2nd Jun 20051:14 pmRNSIssue of Equity
6th Apr 200510:14 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.